DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Manns M, Samuel D, Gane EJ. , et al; SOLAR-2 investigators.
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
Lancet Infect Dis 2016;
16 (06) 685-697
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.